Vanguard Total Stock Market ETF (VTI)
331.81
+0.00 (0.00%)
NYSE · Last Trade: Oct 9th, 8:28 AM EDT
Detailed Quote
Previous Close | 331.81 |
---|---|
Open | - |
Day's Range | N/A - N/A |
52 Week Range | 236.42 - 331.99 |
Volume | 5,826 |
Market Cap | 5.46B |
Dividend & Yield | 3.628 (1.09%) |
1 Month Average Volume | 3,818,063 |
Chart
News & Press Releases
Tesla Faces NHTSA Probe Into 2.9M FSD-Equipped Vehiclesstocktwits.com
Via Stocktwits · October 9, 2025
Why TSMC Stock Is Slipping Premarket Today Despite Q3 Revenue Beatstocktwits.com
Via Stocktwits · October 9, 2025
Why Nvidia Stock Is Rising Over 1% In Today’s Premarketstocktwits.com
Via Stocktwits · October 9, 2025
Games like Pictionary: Game Night and Party Crashers will let subscribers play together without leaving Netflix.
Via Stocktwits · October 9, 2025
UiPath Rises After Hitting New 2025 Highs: What’s Behind Stock’s After-Hours Climb?stocktwits.com
Via Stocktwits · October 8, 2025
AMD Stock Extends 43% Weekly Surge With After-Hours Gains: Here’s What’s Driving Itstocktwits.com
Via Stocktwits · October 8, 2025
Tesla Now Has Four Variants Of Model Y, 3 In US, But Fund Manager Thinks It Might Not Be The Case For Much Longerstocktwits.com
Via Stocktwits · October 8, 2025
Confluent’s Sale Could Bring 30% Premium, Says Raymond Jamesstocktwits.com
Via Stocktwits · October 8, 2025
Alphabet’s Google On Verge Of Unveiling Asia’s Largest Data Center Cluster In India With $10B Investment: Reportstocktwits.com
Via Stocktwits · October 8, 2025
Intel Set To Unveil Panther Lake Mobile Chip Specs In Bid To Halt AMD Market Share Gains: Reportstocktwits.com
Via Stocktwits · October 7, 2025
Qualcomm Expands AI Arsenal With Arduino Acquisitionqualcom
Via Stocktwits · October 7, 2025
The analyst’s new price target represents a potential upside of about 12% from the stock’s closing price on Tuesday.
Via Stocktwits · October 8, 2025
JPMorgan lifted its price target for Dell from $145 to $165 and maintained an ‘Overweight’ rating, citing that Dell’s performance metrics revealed during the event not only met but surpassed internal expectations.
Via Stocktwits · October 8, 2025
The xAI deal reportedly envisions a $2 billion contribution by Nvidia, as the former plans to raise $7.5 billion in equity and $12.5 billion in debt financing.
Via Stocktwits · October 8, 2025
Confluent’s stock price plummeted in July following the loss of a major customer, reportedly rendering the company vulnerable to takeover approaches.
Via Stocktwits · October 8, 2025
Tesla Stock Edges Lower Premarket: Retail Traders Feel Bullish As Speculation Swirls About New Revealstocktwits.com
Via Stocktwits · October 7, 2025
Wells Fargo Vouches For Microsoft Cloud Growth With $675 Price Target On Stockstocktwits.com
Via Stocktwits · October 6, 2025
AMC Rides Taylor Swift Movie Hype To Weekend Box Office Record: CEO Lauds ‘Iconic’ Singer Amid Retail Bullishnessstocktwits.com
Via Stocktwits · October 6, 2025
Most analysts viewed the OpenAI deal as signaling the potential broader adoption of AMD’s AI chips across OpenAI’s cloud service provider partners and among other players.
Via Stocktwits · October 8, 2025
Benchmark highlighted increased capital commitments, a rapidly evolving technology ecosystem, and endorsements from major tech players as key drivers of renewed confidence in Rigetti’s growth trajectory.
Via Stocktwits · October 7, 2025
The company announced that it now intends to utilize the net proceeds for working capital and general corporate purposes, in addition to funding the early-stage trial of its CLR 125 compound in triple-negative breast cancer.
Via Stocktwits · October 7, 2025
Modest annual returns can create life-changing wealth over the long term, thanks to the magic of compounding.
Via The Motley Fool · October 7, 2025
Jefferies analysts stated that the OpenAI deal altered AMD’s “AI narrative” and provided “strong validation” of its AI roadmap and the level of AI demand in general.
Via Stocktwits · October 6, 2025
The company stated that the design of the new trial will be based on the learnings from the previous trials, in addition to FDA feedback.
Via Stocktwits · October 6, 2025
For as little as $1, this low-cost ETF gives investors exposure to thousands of companies.
Via The Motley Fool · October 5, 2025